Sphistin (12-38)

General Information


DRACP ID  DRACP00722

Peptide Name   Sphistin (12-38)

Sequence  KAKAKAVSRSARAGLQFPVGRIHRHLK

Sequence Length  27

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma Not active up to 100 µg/ml MTS assay 24h 1

Hemolytic Activity  Crab haemocytes: Not active up to 100 µg/ml

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00722

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C132H228N48O31

Absent amino acids  CDEMNTWY

Common amino acids  A

Mass  344751

Pl  12.99

Basic residues  10

Acidic residues  0

Hydrophobic residues  11

Net charge  10

Boman Index  -6679

Hydrophobicity  -56.3

Aliphatic Index  83.33

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28600196

Title  A truncated Sph12-38 with potent antimicrobial activity showing resistance against bacterial challenge in Oryzias melastigma

Doi 10.1016/j.fsi.2017.06.013

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.